People taking GLP-1 weight loss drugs like Ozempic started moving less
Multiple studies confirm users of GLP-1 weight-loss medications—including Ozempic, Wegovy, Mounjaro, and Zepbound—reduce daily steps and exercise levels even as they lose weight. Researchers warn this decline in physical activity may weaken muscle mass and long-term health. A multinational study further shows exercise combined with GLP-1 therapy yields better sustained benefits. Experts urge patients to maintain activity to offset muscle loss.
What changed
New Fitbit-based research and a multinational study add direct evidence linking GLP-1 drugs to reduced spontaneous physical activity, reinforcing earlier findings with clearer data on muscle preservation and long-term health risks.
Live updates
-
GLP-1 drugs like Ozempic linked to sharp drop in movement despite weight loss
confidence 93%Multiple studies confirm users of GLP-1 weight-loss medications—including Ozempic, Wegovy, Mounjaro, and Zepbound—reduce daily steps and exercise levels even as they lose weight. Researchers warn this decline in physical activity may weaken muscle mass and long-term health. A multinational study further shows exercise combined with GLP-1 therapy yields better sustained benefits. Experts urge patients to maintain activity to offset muscle loss.
What's confirmed:
- Users of GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound show significant drops in daily step counts and exercise levels after starting treatment, despite successful weight loss.
- Fitbit data analysis reveals declines in both step counts and moderate-to-vigorous physical activity among GLP-1 users, raising concerns about muscle mass loss alongside fat reduction.
- A multinational study found that adding structured exercise to GLP-1 therapy improves long-term health benefits, including muscle preservation and metabolic outcomes.
- Experts warn that reduced physical activity while on GLP-1 drugs may compromise strength and long-term health, even if weight loss is achieved.
Still unconfirmed:
- The term 'Ozempic personality' describes real behavioral changes in some users, though it is not an official medical diagnosis.